These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1679388)

  • 21. Human studies of relative abuse liability of benzodiazepines and novel sedatives/anxiolytics.
    Troisi JR; Evans SM; Griffiths RR
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():108A-109A. PubMed ID: 1354019
    [No Abstract]   [Full Text] [Related]  

  • 22. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.
    Fischman MW; Foltin RW
    Br J Addict; 1991 Dec; 86(12):1563-70. PubMed ID: 1786488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepines: abuse and new use.
    Warneke LB
    Can J Psychiatry; 1991 Apr; 36(3):194-205. PubMed ID: 1676343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.
    Griffiths RR; Weerts EM
    Psychopharmacology (Berl); 1997 Nov; 134(1):1-37. PubMed ID: 9399364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abuse of benzodiazepines: the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc.
    Am J Drug Alcohol Abuse; 1988; 14 Suppl 1():1-69. PubMed ID: 2902782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing and abuse liability of drugs in humans.
    Schuster CR
    NIDA Res Monogr; 1989; 92():1-6. PubMed ID: 2512489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics.
    Roache JD
    Adv Alcohol Subst Abuse; 1990; 9(1-2):103-28. PubMed ID: 1974120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepines: reconsidered.
    Miller NS; Gold MS
    Adv Alcohol Subst Abuse; 1990; 8(3-4):67-84. PubMed ID: 1971487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedative drug interactions of clinical importance.
    Cushman P
    Recent Dev Alcohol; 1986; 4():61-83. PubMed ID: 2871595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dependence liability of the benzodiazepines.
    Ladewig D
    Drug Alcohol Depend; 1984 Mar; 13(2):139-49. PubMed ID: 6144497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypnotics--abuse and dependence].
    Hoff P; Nedopil N; Wolf B
    Internist (Berl); 1984 Sep; 25(9):556-8. PubMed ID: 6149200
    [No Abstract]   [Full Text] [Related]  

  • 34. Performance and physiological measures in abuse liability evaluation.
    Roache JD
    Br J Addict; 1991 Dec; 86(12):1595-600. PubMed ID: 1786492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
    Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
    Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zolpidem dependence in a patient with former polysubstance abuse.
    Bottlender R; Schütz C; Möller HJ; Soyka M
    Pharmacopsychiatry; 1997 May; 30(3):108. PubMed ID: 9211573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Griffiths RR; Lamb RJ; Sannerud CA; Ator NA; Brady JV
    Psychopharmacology (Berl); 1991; 103(2):154-61. PubMed ID: 1674158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of five anxiolytic benzodiazepines on measures of psychomotor performance and sleep.
    Hindmarch I; Haller J; Sherwood N; Kerr JS
    Neuropsychobiology; 1990-1991; 24(2):84-9. PubMed ID: 1983701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance dependence and the use of pro re nata anxiolytic/hypnotic drugs in a hospital setting.
    D'Mello DA; Lyon DE; Colenda CC; Fernandes CL
    Addict Behav; 2000; 25(3):441-3. PubMed ID: 10890298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.